Targeting glucose‐6‐phosphate dehydrogenase by 6‐AN induces ROS‐mediated autophagic cell death in breast cancer
暂无分享,去创建一个
Fei Li | Q. Sun | Tianjiao Li | Chenggang Li | Changjun Wang | F. Zheng | Qiaofeng Liu | Yin Li | Yupeng Zhang | Juan Yang | Zhoujun Lin | Zhenkun Fu | Xiao Han | Xiaolin Pei | Yao Feng | Lizhong Yan | Yifan Zhang | Ding-An Li
[1] J. Koo,et al. Glucose Metabolism and Glucose Transporters in Breast Cancer , 2021, Frontiers in Cell and Developmental Biology.
[2] S. Gibson,et al. Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat , 2021, Oxidative medicine and cellular longevity.
[3] Y. Bao,et al. TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose‐6‐phosphate dehydrogenase (G6PD) , 2021, Cell proliferation.
[4] Junjian Wang,et al. S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis. , 2020, Chemico-biological interactions.
[5] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[6] Ping Liu,et al. Deferoxamine Enhanced Mitochondrial Iron Accumulation and Promoted Cell Migration in Triple-Negative MDA-MB-231 Breast Cancer Cells Via a ROS-Dependent Mechanism , 2019, International journal of molecular sciences.
[7] D. Chiu,et al. The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer , 2019, Cells.
[8] M. Caraglia,et al. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation , 2019, Journal of Experimental & Clinical Cancer Research.
[9] R. Parsanathan,et al. Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion: Protective role of l-cysteine. , 2019, Archives of biochemistry and biophysics.
[10] Hong-Sheng Zhang,et al. Nrf2 promotes breast cancer cell migration via up‐regulation of G6PD/HIF‐1α/Notch1 axis , 2019, Journal of cellular and molecular medicine.
[11] J. Yao,et al. ROS-induced autophagy regulates porcine trophectoderm cell apoptosis, proliferation, and differentiation. , 2019, American journal of physiology. Cell physiology.
[12] T. Akinyemiju,et al. Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype , 2018, Breast Cancer Research and Treatment.
[13] Jianhua Wang,et al. MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD , 2018, Oncology letters.
[14] R. Amaravadi,et al. Targeting autophagy in cancer , 2018, Cancer.
[15] Hao Pan,et al. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro. , 2018, International journal of oncology.
[16] M. Miyagishi,et al. Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway. , 2018, Cancer research.
[17] K. Ghoshal,et al. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer , 2018, Scientific Reports.
[18] M. Caraglia,et al. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo , 2018, Cell Death & Disease.
[19] A. Nadeem,et al. Glucose‐6‐phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase‐derived reactive oxygen species , 2018, Clinical and experimental immunology.
[20] J. Liu,et al. Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer , 2017, Oncogene.
[21] Yuechun Zhu,et al. Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma , 2017, Journal of Cancer.
[22] O. Fiehn,et al. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes. , 2016, Cancer letters.
[23] Ji‐Won Kim,et al. Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity , 2016, Diabetes.
[24] Minghui Zhang,et al. Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma , 2015, World Journal of Surgical Oncology.
[25] Jianquan Hou,et al. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells. , 2015, Molecular medicine reports.
[26] P. Jiang,et al. Regulation of the pentose phosphate pathway in cancer , 2014, Protein & Cell.
[27] I. Martínez-Reyes,et al. The H(+)-ATP synthase: a gate to ROS-mediated cell death or cell survival. , 2014, Biochimica et biophysica acta.
[28] J. Blenis,et al. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells , 2014, Cell Death and Disease.
[29] T. Mak,et al. TAp73 enhances the pentose phosphate pathway and supports cell proliferation , 2013, Nature Cell Biology.
[30] A. Jordan,et al. Novel steroid inhibitors of glucose 6-phosphate dehydrogenase. , 2012, Journal of medicinal chemistry.
[31] Ji‐Won Kim,et al. G6PD up-regulation promotes pancreatic beta-cell dysfunction. , 2011, Endocrinology.
[32] J. Loscalzo,et al. High glucose inhibits glucose‐6‐phosphate dehydrogenase, leading to increased oxidative stress and β‐cell apoptosis , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] J. Loscalzo,et al. Glucose‐6‐phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] H. Barrach,et al. Inhibition of NADP dependent oxidoreductases by the 6‐aminonicotinamide analogue of NADP , 1970, FEBS letters.
[35] Y. Murakumo,et al. Prognostic significance of G6PD expression and localization in lung adenocarcinoma. , 2019, Biochimica et biophysica acta. Proteins and proteomics.
[36] R. Mittler. ROS Are Good. , 2017, Trends in plant science.